Societal CDMO (formerly Recro) Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Societal CDMO (formerly Recro)'s estimated annual revenue is currently $68.1M per year.(i)
  • Societal CDMO (formerly Recro)'s estimated revenue per employee is $201,000

Employee Data

  • Societal CDMO (formerly Recro) has 339 Employees.(i)
  • Societal CDMO (formerly Recro) grew their employee count by -5% last year.

Societal CDMO (formerly Recro)'s People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
CEOReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
VP FinanceReveal Email/Phone
6
VP Operations & Site HeadReveal Email/Phone
7
VP, Regulatory Affairs and PharmacovigilanceReveal Email/Phone
8
VP Business DevelopmentReveal Email/Phone
9
SVP OperationsReveal Email/Phone
10
VP, Supply ChainReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$102.7M51125%N/AN/A
#2
$0.4M20%N/AN/A
#3
$38.6M1923%N/AN/A
#4
$35M1272%$62.5MN/A
#5
$36.6M18218%N/AN/A
#6
$131.9M656-3%N/AN/A
#7
$133.5M664N/AN/AN/A
#8
$72.8M362-4%N/AN/A
#9
$551.9M1716-2%N/AN/A
#10
$11.7M5812%N/AN/A
Add Company

What Is Societal CDMO (formerly Recro)?

Societal CDMO is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services the global pharmaceutical market. In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, totaling 145,000 square feet, in Gainesville, Georgia, and San Diego, California.

keywords:N/A

N/A

Total Funding

339

Number of Employees

$68.1M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$52.5M3395%N/A
#2
$104.1M3400%N/A
#3
$115.4M34238%N/A
#4
$77M34238%N/A
#5
$7.5M34515%N/A